EUDA Health (EUDA) vs Nakamoto (NAKA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
EUDA Health (EUDA) has outperformed Nakamoto (NAKA) over the past year, losing 71.8% versus a loss of 80.6%. Nakamoto is the larger company by market cap ($63.1 million vs $47.8 million), about 1.3 times the size, while EUDA Health is growing revenue faster (+70.0% vs -33.0%). EUDA Health converts more of its revenue into profit, with a net margin of -40.7% versus -2867.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EUDA | NAKA |
|---|---|---|
| Share price | $15.96 | $3.44 |
| Market cap | $47.79M | $63.11M |
| 1-day change | -7.69% | -15.89% |
| YTD return | -65.45% | -75.50% |
| 1-year return | -71.80% | -80.59% |
| P/E ratio (TTM) | — | 0.14 |
| Forward P/E | 9.97 | — |
| EPS (TTM) | $-1.18 | $24.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $6.82M | $1.82M |
| Revenue growth (YoY) | +70.04% | -33.04% |
| Net income (latest FY) | $-2.77M | $-52.23M |
| Gross margin | 43.88% | — |
| Operating margin | -36.33% | -10824.01% |
| Net margin | -40.65% | -2867.65% |
| 52-week high | $68.00 | $23.20 |
| 52-week low | $5.26 | $3.33 |
| Distance from 52-week high | -76.53% | -85.17% |
| Analyst consensus | none | none |
| Avg. price target upside | +244.61% | +287.50% |
| Average volume | 37.77K | 197.37K |
| Shares outstanding | 2.99M | 18.35M |
| Employees | 123 | 33 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EUDA Health is more profitable, keeping -40.7 cents of every revenue dollar as net income versus -2867.6 cents for Nakamoto.
- EUDA Health grew revenue faster in its latest fiscal year (+70.04% vs -33.04%).
About EUDA Health
EUDA stock →EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services.
Health Care · Medical/Nursing Services · 123 employees
About Nakamoto
NAKA stock →Nakamoto Inc. develops and invests in a global portfolio of Bitcoin-native companies.
Health Care · Medical/Nursing Services · 33 employees
EUDA vs NAKA FAQ
Which is bigger, EUDA Health or Nakamoto?
Nakamoto (NAKA) is larger, with a market capitalization of $63.11M compared with $47.79M for EUDA Health (EUDA).
Which stock has performed better over the past year, EUDA or NAKA?
EUDA returned -71.80% over the past 12 months, compared with -80.59% for NAKA (price return, excluding dividends). Past performance does not predict future results.
Are EUDA Health and Nakamoto in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.